World leader in the field of spinal cord neuromodulation Prof Reggie Edgerton is interviewed in this “people behind the science” podcast.
Month: March 2015
Non-invasive device instantly diagnoses urinary tract infections
A wireless, credit-card sized optical device shows promise for diagnosing lower urinary tract infections (UTIs), especially in children, the elderly and people with neurological conditions. Dr Babak Shadgan and his colleagues were able to diagnose UTI in 12 pediatric…
Scientific research is like owning a cat…
#science #phdproblems pic.twitter.com/D6MvhNlyMD Follow TwistedDoodles on Twitter @twisteddoodles
UCSF team finds key to making neurons from stem cells
A research team at UC San Francisco has discovered an RNA molecule called Pnky that can be manipulated to increase the production of neurons from neural stem cells. The research, led by neurosurgeon Daniel A. Lim, MD, PhD, and published…
What is a neural stem cell?
https://vimeo.com/118301922 Everything you always wanted to know about neural stem cells in just over 1 minute CREDITS Narration by: Dr. Sam Weiss Written & Directed by: Ben Paylor & Mike Long Produced by: Infoshots – infoshots.ca Animation by: David Murawsky…
Cancer drug epothilone causes damaged nerve cells in spinal cord injuries to regrow
A new study from German scientists shows that, in animal studies, the cancer drug epothilone reduced the formation of scar tissue in injuries to the spinal cord and stimulated growth in damaged nerve cells. Both promoted neuronal regeneration and improved…
A visit from the Macarthur Lions
Recently we received a very welcome visit from friends from the MacArthur Lions Club who have been great supporters for many years. With them they brought a cheque for the tidy sum of $9000 – the proceeds from the last SpinalCure Golf…
$20m Conquer Paralysis Now Grand Challenge launched in UK
A new approach to finding Cures: The CPN Challenge plans to award almost $20m worth of awards and prizes over the next 10 years with a $10m Grand Prize awarded to the first team that reaches unprecedented improvement in every…
Phase 1/2a stem cell trial for acute spinal cord injury begins
Asterias Biotherapeutics has initiated patient enrolment for its Phase 1/2a clinical trial of AST-OPC1 stem cells for treating newly injured people with complete cervical spinal cord injury. “The Phase 1 study generated a strong package of data regarding the safety of AST-OPC1,” said…